Mo Mo Tin

450 total citations
15 papers, 337 citations indexed

About

Mo Mo Tin is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Surgery. According to data from OpenAlex, Mo Mo Tin has authored 15 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Otorhinolaryngology and 5 papers in Surgery. Recurrent topics in Mo Mo Tin's work include Head and Neck Cancer Studies (6 papers), Pleural and Pulmonary Diseases (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Mo Mo Tin is often cited by papers focused on Head and Neck Cancer Studies (6 papers), Pleural and Pulmonary Diseases (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Mo Mo Tin collaborates with scholars based in Australia, Belgium and Canada. Mo Mo Tin's co-authors include Michael Boyer, Khin Khin Htwe, Jocelyn McLean, Brian C. McCaughan, Tristan D. Yan, Paul G. Bannon, Catherine J. Kennedy, Daniel Wong, Michael Jackson and Kerwin F. Shannon and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Thoracic and Cardiovascular Surgery and The Annals of Thoracic Surgery.

In The Last Decade

Mo Mo Tin

15 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mo Mo Tin Australia	10	189	96	77	70	57	15	337
Surendra Pal Chaudhary India	5	245 1.3×	65 0.7×	216 2.8×	240 3.4×	9 0.2×	12	417
T. Iizuka Japan	4	180 1.0×	5 0.1×	52 0.7×	195 2.8×	5 0.1×	8	282
Garazi Serna Spain	10	58 0.3×	7 0.1×	87 1.1×	23 0.3×	44 0.8×	15	254
Aliu Akano Nigeria	6	15 0.1×	30 0.3×	33 0.4×	31 0.4×	9 0.2×	6	320
Sravanti Rangaraju United States	5	35 0.2×	16 0.2×	42 0.5×	6 0.1×	8 0.1×	18	179
Robert Kieszko Poland	10	106 0.6×	4 0.0×	61 0.8×	21 0.3×	5 0.1×	35	237
Travis T. Sims United States	8	23 0.1×	7 0.1×	52 0.7×	35 0.5×	27 0.5×	28	227
Haojie Feng China	7	29 0.2×	4 0.0×	74 1.0×	52 0.7×	14 0.2×	9	320
Jason Girkin Australia	10	74 0.4×	7 0.1×	19 0.2×	23 0.3×	2 0.0×	14	352
Alessandra Cuomo Italy	12	98 0.5×		95 1.2×	24 0.3×	22 0.4×	29	299

Countries citing papers authored by Mo Mo Tin

Since Specialization

Citations

This map shows the geographic impact of Mo Mo Tin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Mo Tin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Mo Tin more than expected).

Fields of papers citing papers by Mo Mo Tin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mo Mo Tin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Mo Tin. The network helps show where Mo Mo Tin may publish in the future.

Co-authorship network of co-authors of Mo Mo Tin

This figure shows the co-authorship network connecting the top 25 collaborators of Mo Mo Tin. A scholar is included among the top collaborators of Mo Mo Tin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mo Mo Tin. Mo Mo Tin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Lo, Serigne, Shagun Aggarwal, Angela Hong, et al.. (2021). Validation of the American Joint Committee on Cancer Staging in Squamous Cell Carcinoma of the Vermilion Lip. Annals of Surgical Oncology. 28(6). 3092–3099. 1 indexed citations

2.

Tin, Mo Mo, et al.. (2015). Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Toxicity and outcomes at an Australian institution. Journal of Medical Imaging and Radiation Oncology. 59(3). 355–362. 10 indexed citations

3.

Ralston, Anna, et al.. (2014). In vivoand phantom measurements versus Eclipse TPS prediction of near surface dose for SBRT treatments. Journal of Physics Conference Series. 489. 12008–12008. 2 indexed citations

4.

Chatfield, Mark D., et al.. (2013). Outcomes of chemoradiation for patients with locally advanced non‐small‐cell lung cancer. Internal Medicine Journal. 43(7). 790–797. 6 indexed citations

5.

Yan, Tristan D., Christopher Cao, Michael Boyer, et al.. (2011). Improving Survival Results after Surgical Management of Malignant Pleural Mesothelioma: An Australian Institution Experience. Annals of Thoracic and Cardiovascular Surgery. 17(3). 243–249. 15 indexed citations

6.

Yan, Tristan D., Michael Boyer, Mo Mo Tin, et al.. (2009). Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factors. Journal of Thoracic and Cardiovascular Surgery. 138(3). 619–624. 65 indexed citations

7.

Yan, Tristan D., Michael Boyer, Mo Mo Tin, et al.. (2009). Prognostic Features of Long-term Survivors After Surgical Management of Malignant Pleural Mesothelioma. The Annals of Thoracic Surgery. 87(5). 1552–1556. 21 indexed citations

8.

Martin, Richard C., Michael Fulham, Kerwin F. Shannon, et al.. (2008). Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer. Head & Neck. 31(2). 244–250. 26 indexed citations

9.

Htwe, Khin Khin, et al.. (2008). Effect of Saccharomyces boulardii in the Treatment of Acute Watery Diarrhea in Myanmar Children: A Randomized Controlled Study. American Journal of Tropical Medicine and Hygiene. 78(2). 214–216. 63 indexed citations

10.

Ball, David, Bryan Burmeister, Paul Mitchell, et al.. (2007). P2-162: Phase I trial of gefitinib in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non small cell lung cancer (“CRITICAL”). Journal of Thoracic Oncology. 2(8). S633–S634. 10 indexed citations

11.

Featherstone, C., Stephen Clarke, Michael Jackson, et al.. (2004). Treatment of advanced cancer of the larynx and hypopharynx with chemoradiation. ANZ Journal of Surgery. 74(7). 554–558. 6 indexed citations

12.

Clark, Jonathan R., G. Smith, Kerwin F. Shannon, et al.. (2004). Outcome of treatment for advanced cervical metastatic squamous cell carcinoma. Head & Neck. 27(2). 87–94. 38 indexed citations

13.

Rischin, Danny, Bryan Burmeister, Paul Mitchell, et al.. (2004). Phase I trial of gefitinib (ZD1839) in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non-small cell lung cancer. Journal of Clinical Oncology. 22(14_suppl). 7077–7077. 7 indexed citations

14.

Rischin, Danny, Bryan Burmeister, Paul Mitchell, et al.. (2004). Phase I trial of gefitinib (ZD1839) in combination with concurrent carboplatin, paclitaxel and radiation therapy in patients with stage III non-small cell lung cancer. Journal of Clinical Oncology. 22(14_suppl). 7077–7077. 23 indexed citations

15.

Waldron, John, Mo Mo Tin, Anne Keller, et al.. (2003). Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma. Radiotherapy and Oncology. 68(2). 153–161. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact